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Chlamydiae, and plant plastids, and
uses a specific DNA probe. We con-
siderably decreased the risk of hori-
zontal and vertical contamination of
the PCR reaction by using uracil and
uracil-N-glycosylase and by keeping
reaction cups closed since the first
amplification cycle.
More importantly, our study
showed that Parachlamydia DNA is
rarely found in bronchoalveolar
lavage samples (0.083%). This sug-
gests that persons are infrequently
exposed to Parachlamydia organisms
and, consequently, members of the
Parachlamydiaceae seldom cause
pneumonia in humans. In the only
positive sample, whether Para-
chlamydia originated from bacteria in
the oropharynx, from water, or from a
colonization of the lower respiratory
tract was not known; whether they
caused the patient’s pneumonia is also
not known. That two strains of
Parachlamydia found in amoebae
were recovered from the nasopharynx
of healthy volunteers (7) favors the
first hypothesis. However, that the
positive broncholaveolar lavage spec-
imen was taken from an HIV-positive
patient with community-acquired
pneumonia suggests that Parachla-
mydia might occasionally play a path-
ogenic role in AIDS patients.
Moreover, any amoebae-associated
bacteria should be considered as a
potential emerging pathogen because
intra-amoebal growth may lead to the
selection of virulence traits and to the
adaptation to professional phago-
cytes, such as alveolar macrophages
(1,2). Further studies are warranted to
determine whether Parachlamy-
diaceae causes community-acquired
pneumonia, particularly in HIV-
infected persons.
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Hantaviruses in the
Czech Republic
To the Editor: Infections caused
by hantaviruses have been known for
a long time, but their causative agent
was not detected until 1976 (1). These
viruses of the genus Hantavirus, fam-
ily Bunyaviridae, have >20 geno-
types. Hantaviruses circulate in wild
rodents within natural foci over
Euroasia and North and South
America. They cause asymptomatic
persistent infections in these small
mammals. Humans may acquire
infection accidentally from inhalation
of virus-contaminated aerosols of
rodent excreta. Hantavirus genotypes
may be nonpathogenic for humans or
cause serious diseases with high death
rates. In Eurasia, these pathogens
involve primarily the kidney and
cause hemorrhagic fever with renal
syndrome; in North and South
America, these pathogens involve pri-
marily the lung and cause hantavirus
cardiopulmonary syndrome.
First reports on the occurrence of
hantaviruses in central Europe origi-
nated from former Czechoslovakia
(2,3) and Germany (4) and date back
to 1984 and 1985, respectively. The
first cases of hantavirus disease in
humans in the Czech Republic were
reported in 1992 (5). This flulike dis-
ease accompanied by microhematuria
was recorded in southern Moravia.
Another severe imported case was
described in a soldier on active mili-
tary duty in the Balkans (6). The first
isolation of nonpathogenic hantavirus
Tula was reported in the Czech
Republic (7). Currently, several han-
tavirus infections have been recorded
in humans, manifesting mainly as
interstitial nephritis. One fatal case
was also reported in a patient who had
never travelled outside the Czech
Republic.
We conducted studies of hantavirus
ecology in the Czech Republic and
hantavirus seroprevalence in the Czech
population. As in neighboring Slovakia
(8), hantaviruses of three genotypes,
i.e., Dobrava, Puumala, and Tula, were
identified in the Czech Republic. Most
serious infections are caused by the
Dobrava genotype; Tula genotype
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remains nonpathogenic for humans,
although a case of human infection
without clinical signs has been
described in the Czech Republic (9).
Blood serum samples from 710
randomly selected persons >20 years
of age from the Czech Republic were
screened for antibodies against
Puumala and Hantaan antigens with
commercial enzyme-linked immuno-
sorbent assay (ELISA) sets manufac-
tured by PROGEN (Biotechnik,
Heidelberg, Germany). The Hantaan
antigen was used because of its anti-
genic relatedness with Dobrava virus,
which is not included in available
commercial ELISA sets.
Five participants showed immuno-
globulin (Ig) G reactivity to Hantaan
virus (cross-reactive with Dobrava
antigen), and two participants tested
positive for both IgG and IgM anti-
bodies. Two other persons showed
IgM reactivity alone. These findings
indicate that as many as seven (1.0%)
study participants showed reactivity
to Hantaan antigen. Eight persons
showed IgG reactivity to Puumala
antigen, none of them IgM positive.
Altogether, 10 (1.4%) study partici-
pants were reactive to Puumala anti-
gen. Three persons showed reactivity
to both antigens tested.
A total of 1,494 small mammals of
different Czech regions were screened
with ELISA for hantavirus antigen in
the lungs. The antigen was detected in
the lungs of 101 animals; the highest
positivity rate was in Common Voles
(Microtus arvalis). The difference in
positivity between male and female
voles was not statistically significant.
The positivity rate was markedly
associated with rodent size. With the
use of molecular genetic methods
(polymerase chain reaction), genotype
Tula was identified as the causative
agent of infection in rodents.
Genotype Puumala was identified in
bank voles (Clethrionomys glareolus)
in Moravia. Nucleotide sequences
of Dobrava genotype were identified
in southern Bohemian rodents
(K. Krivanec, pers. comm.).
In the Czech Republic, Tula virus
is the most frequent hantavirus circu-
lating in Common Voles. This agent is
not pathogenic for humans. The han-
tavirus seroprevalence rate in the
adult population of the Czech
Republic is close to 1%. Dobrava and
Puumala viruses are causative agents
of these infections in humans. 
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Antibiotics and
Airline Emergency
Medical Kits
To the Editor: Medical events
during airline flights have drawn some
attention in recently published articles
and letters (1–4). We would like to
share our experience of meningococ-
cemia/ and meningococcal meningitis
during a transatlantic flight.
In June 2000, a 20-year-old stu-
dent with a mild viral illness (diag-
nosed before the flight) boarded a
flight from Tel-Aviv, Israel, to
Newark, New-Jersey, USA (approxi-
mate flight time, 11–12 hours), with a
tour group of college-age students and
their chaperones. We, a neonatologist
and a neonatal intensive care nurse,
were on the same flight to later trans-
port a prematurely born infant from
the United States back to Israel.
About 90 minutes before landing
in New Jersey, the chief flight atten-
dant asked me (B.B-O.) to check the
passenger, who said he did not feel
well. His medical history indicated no
past illness, which was corroborated
by the director of the tour group. The
patient reported general malaise and
numbness in his feet. In the 2 weeks
before the flight, he had traveled in
Israel, visiting cities, caves, and
mountains. He and his group had slept
in different hostels in those areas. 
On examination, he was fully con-
scious, and his blood pressure and
